CNS Lymphoma Clinical Trial
Official title:
A Prospective Imaging and Translational Tissue Study in CNS Lymphoma to Enable Further Disease Characterisation and the Development of Potential Predictive and Prognostic Biomarkers
A prospective imaging and translational tissue study in CNS lymphoma to enable further disease characterisation and the development of potential predictive and prognostic biomarkers.
As a single centre exploratory study, this trial will recruit patients with newly diagnosed primary CNS lymphoma and will look at the molecular aspects of the disease in the tissue collection and imaging response assessments using CCA with respect to progression free survival. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05117814 -
Zanubrutinib Monotherapy in Relapsed/Refractory Central Nervous System Lymphoma
|
N/A | |
| Terminated |
NCT05222269 -
[68Ga]Ga-PentixaFor PET Imaging in CNS Lymphoma Patients
|
Phase 2 | |
| Recruiting |
NCT06132737 -
[90Y]Y-PTT Endoradiotherapy in CNS Lymphoma Patients
|
Phase 1/Phase 2 | |
| Terminated |
NCT05242146 -
GB5121 in Adult Patients With Relapsed/Refractory CNS Lymphoma
|
Phase 1 | |
| Not yet recruiting |
NCT06343311 -
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
|
Phase 1/Phase 2 | |
| Completed |
NCT01319591 -
Comparison of Creatinine Clearance Calculation for Estimation of GFR in Patients Receiving HD Methotrexate
|
||
| Recruiting |
NCT05351593 -
Tafasitamab Plus Lenalidomide in Relapsed CNS Lymphoma
|
Phase 1/Phase 2 | |
| Completed |
NCT01182415 -
High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin's Lymphoma or Central Nervous System (CNS) Lymphoma
|
Phase 2 | |
| Recruiting |
NCT04841434 -
A Phase I/II Study to Investigate the Use of VORAXAZE™ as Intended Intervention in Patients With CNSL
|
Phase 1/Phase 2 | |
| Completed |
NCT01083342 -
High-Dose (HD) Methotrexate (MTX) Induction Chemotherapy Followed by Alternative HD MTX-based and HD Cytarabine-based Combination Consolidation Chemotherapy for Newly Diagnosed Primary CNS Lymphoma; CISL 10-01 Study
|
Phase 2 | |
| Completed |
NCT05293990 -
Usefulness of Gadovist-enhanced FLAIR Imaging
|
N/A | |
| Completed |
NCT00596154 -
Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma
|
Phase 2 | |
| Recruiting |
NCT05926427 -
Orelabrutinib Combined With Rituximab and Chemotherapy for Relapsed/Refractory B-Cell Lymphoma Patients With Central Nervous System Involvement
|
Phase 2 |